Tazverik approved to treat metastatic, locally advanced epithelioid sarcoma
Sunday, January 26, 2020 - 08:30
in Health & Medicine
Tazverik has received the first approval for treatment of adults and pediatric patients 16 years and older with metastatic or locally advanced epithelioid sarcoma that cannot be resected, the U.S. Food and Drug Adm